Nucleic Acid Quantification Using the Bioanalyzer and TapeStation: Microfluidic Capillary Electrophoresis for DNA and RNA Analysis

Microfluidic capillary electrophoresis systems, such as the Agilent Bioanalyzer and TapeStation, provide automated, high-resolution quantification and integrity assessment of DNA and RNA samples using nanoliter-scale sample volumes and disposable microfluidic chips or screen tapes. This method is particularly useful when sample quantity is limited, when both concentration and size distribution are needed from a single analysis, or when assessing nucleic acid integrity for downstream applications such as next-generation sequencing, quantitative PCR, or RNA-based therapeutics. Unlike spectrophotometric or fluorometric methods that measure total nucleic acid content, microfluidic electrophoresis separates molecules by size, enabling simultaneous determination of concentration, fragment length, and degradation status.

At a Glance

Scientific Principle of Microfluidic Capillary Electrophoresis

Microfluidic capillary electrophoresis separates nucleic acid fragments based on their electrophoretic mobility through a sieving polymer matrix contained within microchannels etched into a glass or plastic chip. The fundamental principle is identical to traditional gel electrophoresis: negatively charged nucleic acid molecules migrate toward the positive electrode when an electric field is applied, with smaller molecules moving faster through the polymer network than larger ones.

In the Bioanalyzer system, a disposable microfluidic chip contains an interconnected network of channels filled with a linear polyacrylamide gel matrix and a fluorescent dye that intercalates into nucleic acids. The chip is loaded with samples, a ladder (size standard), and a gel-dye mix. During operation, electrokinetic injection delivers a precisely controlled nanoliter volume from each sample well into the separation channel. As the separated fragments pass a laser-induced fluorescence detector, the instrument records fluorescence intensity over time, generating an electropherogram. The TapeStation system uses a similar principle but employs a tape-based format where samples are loaded into individual wells on a screen tape, and separation occurs through a polymer matrix within the tape's microfluidic channels.

The relationship between migration time and fragment size is established using a ladder containing fragments of known sizes. The instrument software automatically converts migration times to molecular weights and integrates peak areas to calculate concentration based on the ladder's known concentration. This automated sizing and quantification distinguishes microfluidic electrophoresis from traditional agarose gel analysis, where quantification requires post-separation imaging and densitometry, as described in the ImageJ-based quantification approach by Tomlinson et al. [1].

Instrumentation and Materials Selection

Instrument Platforms

The two most common microfluidic electrophoresis platforms for nucleic acid analysis are the Agilent 2100 Bioanalyzer and the Agilent 4200 TapeStation. Both systems provide comparable data quality but differ in throughput, consumable format, and workflow.

Agilent 2100 Bioanalyzer: This system uses individual microfluidic chips that process up to 12 samples per run. Each chip requires manual preparation, including loading the gel-dye matrix into specific wells and pressurizing the chip using a syringe-based priming station. The Bioanalyzer offers multiple assay kits for different nucleic acid types, including DNA 1000, DNA 12000, High Sensitivity DNA, RNA 6000 Nano, RNA 6000 Pico, and Small RNA kits. The choice of kit depends on the expected concentration range and fragment sizes.

Agilent 4200 TapeStation: This system uses screen tapes containing 16 or 96 sample wells pre-filled with separation matrix. Samples are loaded directly into the tape wells, and the instrument automatically draws sample into the separation channel. The TapeStation offers higher throughput than the Bioanalyzer and requires less hands-on time for chip preparation. Available assays include Genomic DNA ScreenTape, D1000 and D5000 ScreenTape for DNA fragments, High Sensitivity D1000 and D5000, RNA ScreenTape, and RNA Integrity Number (RIN) assays.

Assay Kit Selection

Selecting the appropriate assay kit is critical for accurate quantification. Key considerations include:

Expected concentration range: Each kit has a specified quantification range. For example, the DNA 1000 kit for the Bioanalyzer quantifies from 0.5 to 50 ng/µL, while the High Sensitivity DNA kit detects as low as 5 pg/µL. Using a kit with insufficient sensitivity will fail to detect low-concentration samples, while using an overly sensitive kit with high-concentration samples may saturate the detector.

Expected fragment size range: Different kits are optimized for different size ranges. The DNA 1000 kit resolves fragments from 25 to 1000 bp, while the DNA 12000 kit covers 100 to 12000 bp. For genomic DNA analysis, the Genomic DNA ScreenTape (TapeStation) or the DNA 12000 kit (Bioanalyzer) is appropriate.

RNA analysis requirements: For total RNA, the RNA 6000 Nano kit (Bioanalyzer) or RNA ScreenTape (TapeStation) provides RIN values. For degraded or low-concentration RNA samples, the RNA 6000 Pico kit offers higher sensitivity. Small RNA analysis requires dedicated kits optimized for the 6–150 nucleotide range.

Consumables and Reagents

Each assay kit includes specific consumables: microfluidic chips or screen tapes, gel matrix, dye concentrate, marker (internal size standard), and ladder. These components are lot-specific and should not be interchanged between different kit types. The gel-dye mix must be prepared fresh before each Bioanalyzer chip run and protected from light to prevent dye photobleaching. For TapeStation systems, the screen tapes come pre-loaded with separation matrix, eliminating the need for manual gel preparation.

Sample Preparation Considerations

Samples should be free of particulates that could clog microfluidic channels. Centrifuge samples at maximum speed for 1 minute before loading to pellet any debris. For genomic DNA samples, avoid excessive shearing during pipetting; use wide-bore pipette tips when handling high-molecular-weight DNA. Samples containing high concentrations of salts, detergents, or organic solvents may interfere with electrophoresis and should be purified or diluted before analysis. The presence of proteins can also affect migration; ensure samples are adequately purified using column-based cleanup or ethanol precipitation [6].

Controls and Standards

Proper controls are essential for reliable quantification and troubleshooting. Include the following in each run:

Ladder (Size Standard): Every assay kit includes a ladder containing fragments of known sizes and concentrations. The ladder must be run in at least one well per chip or tape to enable size calibration and concentration calculation. The instrument software uses the ladder's migration times and peak areas to generate a standard curve.

Positive Control: Include a sample of known concentration and integrity, such as a commercially available DNA or RNA standard. This control verifies that the assay is performing correctly and provides a benchmark for comparing unknown samples.

Negative Control (No-Template Control): Include a sample containing only the elution buffer or nuclease-free water. This control identifies contamination or carryover from previous runs and establishes the baseline fluorescence signal.

Replicate Samples: For critical applications, run technical replicates to assess precision. The coefficient of variation for concentration measurements is typically 10–20% for microfluidic electrophoresis, which is higher than fluorometric methods but acceptable for most applications.

Conceptual Workflow

Bioanalyzer Workflow

1. Prepare gel-dye mix: Equilibrate the gel matrix and dye concentrate to room temperature for 30 minutes. Vortex the dye concentrate, then add the appropriate volume to the gel matrix. Vortex thoroughly and centrifuge at maximum speed for 10 minutes to pellet any bubbles or particulates.

2. Prime the chip: Place a new chip in the priming station. Pipette the gel-dye mix into the designated well and apply pressure using the syringe for exactly 60 seconds. Release the pressure, then pipette gel-dye mix into the remaining gel wells.

3. Load ladder and samples: Pipette the ladder into the ladder well. Pipette 1 µL of each sample into the sample wells. Add 1 µL of marker (internal standard) to each well containing sample or ladder.

4. Vortex and run: Place the chip in the vortexer for 60 seconds to mix samples with marker. Insert the chip into the Bioanalyzer and start the run. The run time is approximately 30 minutes for a 12-sample chip.

5. Data analysis: The instrument software automatically generates electropherograms, gel-like images, and concentration tables. Review the results for quality indicators such as marker peak position and baseline noise.

TapeStation Workflow

1. Prepare samples: Mix 1–2 µL of each sample with the appropriate volume of loading buffer (typically 2–10 µL, depending on the assay). Centrifuge briefly to collect contents.

2. Load screen tape: Place the screen tape in the TapeStation instrument. Open the tape lid and load samples into the designated wells.

3. Start run: Close the tape lid and start the run. The instrument automatically draws samples into the separation channels. Run time varies by assay but is typically 1–2 minutes per sample.

4. Data analysis: The TapeStation software generates electropherograms, gel images, and concentration data. For RNA assays, the software calculates RIN values automatically.

Quality Checks and Data Interpretation

Electropherogram Quality Indicators

Examine each electropherogram for the following quality indicators:

Marker Peak: Every sample should show a sharp, well-defined marker peak (internal standard) at the expected migration time. The marker peak confirms that the sample was successfully injected and that the electrophoresis system is functioning correctly. If the marker peak is absent or shifted, the sample may not have been loaded properly, or there may be a problem with the chip or tape.

Baseline Noise: The baseline should be flat and low, with no significant drift or spikes. Elevated baseline may indicate contamination, degraded reagents, or problems with the gel-dye matrix.

Peak Shape: Individual peaks should be sharp and symmetrical. Broad or tailing peaks may indicate sample degradation, overloading, or suboptimal separation conditions.

Ladder Performance: The ladder should produce well-resolved peaks at the expected sizes. If ladder peaks are missing, shifted, or poorly resolved, the size calibration will be inaccurate, and all sample data from that run should be considered unreliable.

DNA Integrity Number (DIN)

The DNA Integrity Number is a metric calculated by the TapeStation software for genomic DNA samples. DIN values range from 1 (highly degraded) to 10 (intact). The DIN is derived from the electropherogram profile, considering the ratio of high-molecular-weight DNA to degradation products. A DIN above 8 generally indicates high-quality genomic DNA suitable for long-read sequencing or optical mapping. DIN values between 5 and 8 indicate moderate degradation, while values below 5 suggest significant degradation that may compromise downstream applications.

RNA Integrity Number (RIN)

The RNA Integrity Number is a standardized metric for assessing RNA quality. RIN values range from 1 (completely degraded) to 10 (fully intact). The algorithm considers the entire electropherogram trace, including the ratio of 28S to 18S ribosomal RNA peaks, the presence of degradation products, and the baseline between the ribosomal peaks. A RIN of 8 or higher is generally considered acceptable for most RNA-seq applications, while RIN values below 6 indicate significant degradation that may affect quantitative results. The RIN algorithm is instrument- and kit-specific; values from different platforms are not directly comparable.

Concentration Calculation

The instrument software calculates concentration by comparing the area under each peak to the area of the corresponding ladder peak, accounting for the known concentration of the ladder. For complex samples such as genomic DNA or total RNA, the software integrates the entire electropherogram trace (excluding the marker peak and any system artifacts) to calculate total nucleic acid concentration. For individual fragments, such as PCR products or restriction digests, the software identifies and integrates individual peaks.

Troubleshooting

Limitations and Method Comparisons

Limitations of Microfluidic Electrophoresis

Dynamic Range: The quantification range of microfluidic electrophoresis is narrower than fluorometric methods such as the Qubit or Picogreen assay. Samples outside the assay's dynamic range may give inaccurate results. For example, the Bioanalyzer DNA 1000 kit quantifies from 0.5 to 50 ng/µL, while the Qubit dsDNA HS assay covers 0.2–100 ng/µL with a broader linear range.

Precision: The coefficient of variation for concentration measurements is typically 10–20%, compared to 5–10% for fluorometric methods. This lower precision is acceptable for qualitative assessment and size estimation but may be insufficient for applications requiring exact quantification, such as library normalization for next-generation sequencing.

Cost: Per-sample cost is higher than agarose gel electrophoresis and comparable to or higher than fluorometric assays. The requirement for proprietary chips or tapes and kit-specific reagents limits cost reduction through bulk purchasing.

Size Resolution: While microfluidic electrophoresis provides better resolution than agarose gels for fragments under 1000 bp, resolution decreases for larger fragments. For genomic DNA analysis, the system can indicate integrity but cannot resolve individual fragments.

Comparison with Other Methods

Spectrophotometry (Nanodrop): Spectrophotometric methods measure total nucleic acid concentration based on absorbance at 260 nm but cannot distinguish between DNA, RNA, and contaminants. Microfluidic electrophoresis provides size information and integrity assessment that spectrophotometry cannot.

Fluorometric Assays (Qubit, Picogreen): Fluorometric methods offer higher sensitivity and precision for concentration measurement but provide no size or integrity information. For applications requiring both concentration and quality assessment, microfluidic electrophoresis is the preferred single-assay solution.

Agarose Gel Electrophoresis: Traditional agarose gels are less expensive but require post-separation staining and imaging. Quantification by gel densitometry, as described by Tomlinson et al. [1], can provide semi-quantitative results but lacks the automation and precision of microfluidic systems. Agarose gels also require larger sample volumes (100–500 ng per lane) compared to 1–2 ng for the Bioanalyzer.

Documentation and Reporting

Document the following information for each analysis:

Run Metadata: Instrument serial number, assay kit lot number and expiration date, chip or tape ID, run date and time, operator name.

Sample Information: Sample ID, source, extraction method, storage conditions, dilution factor (if any), expected concentration range.

Quality Control Data: Ladder performance (peak positions and resolution), marker peak position for each sample, baseline quality assessment, any anomalies observed during the run.

Results: Concentration for each sample (with units), size distribution (range and peak sizes), integrity metrics (RIN or DIN), electropherogram images, gel-like image.

Interpretation: Assessment of sample quality and suitability for downstream applications. Note any deviations from expected results and potential causes.

Store raw data files (electropherogram traces) and instrument-generated reports in a secure, backed-up location. Many laboratories maintain electronic laboratory notebooks with linked data files to ensure traceability.

Biosafety Considerations

Microfluidic electrophoresis of nucleic acids extracted from BSL-1 organisms or recombinant DNA constructs falls under standard molecular biology biosafety practices. Follow these guidelines:

Sample Handling: Treat all nucleic acid samples as potentially biohazardous if derived from unknown or environmental sources. Work in a designated molecular biology area with appropriate personal protective equipment (lab coat, gloves, safety glasses).

Decontamination: Decontaminate work surfaces with 10% bleach or 70% ethanol before and after sample handling. Dispose of used chips, tapes, and pipette tips in appropriate biohazard waste containers.

Recombinant DNA: If working with recombinant or synthetic nucleic acid molecules, follow the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules [4]. Ensure institutional biosafety committee approval for the work.

RNA Work: When working with RNA, use RNase-free consumables and reagents. Treat work surfaces with RNase decontamination solutions. Keep samples on ice and minimize handling time to prevent degradation.

Spill Management: In case of sample spillage, immediately cover the area with absorbent material and apply 10% bleach solution. Allow 20 minutes contact time before cleanup. Report significant spills to the laboratory supervisor.

For comprehensive biosafety guidance, refer to the Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition [3].

Frequently Asked Questions

1. Can I use the Bioanalyzer or TapeStation to quantify DNA in the presence of RNA? No, these systems cannot distinguish between DNA and RNA unless using RNA-specific assays that include RNase treatment steps. For mixed samples, the total nucleic acid concentration will be reported, but the individual contributions of DNA and RNA cannot be determined. If you need to quantify DNA in the presence of RNA, use a fluorometric DNA-specific assay such as the Qubit dsDNA assay or treat the sample with RNase before microfluidic analysis.

2. Why does my genomic DNA sample show a low DIN even though it appears intact on an agarose gel? Agarose gels have limited resolution for high-molecular-weight DNA and may not reveal subtle degradation that the TapeStation's DIN algorithm detects. The DIN calculation considers the entire size distribution, including small degradation products that may not be visible on a gel. Low DIN values may also result from mechanical shearing during pipetting or from the presence of contaminants that affect electrophoretic mobility. Use wide-bore pipette tips and minimize vortexing of genomic DNA samples.

3. How should I store and handle the gel-dye mix for the Bioanalyzer? The gel-dye mix should be prepared fresh before each chip run. After preparation, protect it from light by wrapping the tube in aluminum foil. The prepared mix can be stored at 4°C for up to 24 hours, but best results are obtained with freshly prepared mix. Do not freeze the prepared mix, as freezing can cause precipitation of the polymer matrix. The gel matrix and dye concentrate should be stored according to the manufacturer's instructions, typically at 4°C for the gel and room temperature for the dye.

4. What is the minimum sample volume required for analysis? For the Bioanalyzer, you need at least 1 µL of sample per analysis, but it is recommended to have 2–3 µL to account for pipetting losses. For the TapeStation, the required sample volume depends on the assay but is typically 1–2 µL mixed with loading buffer. In both cases, the actual volume consumed during analysis is in the nanoliter range; the excess volume is necessary for reliable pipetting and to ensure the sample reaches the injection point in the microfluidic channel.

References and Further Reading

1. Tomlinson C, Rajasekaran A, Brochu-Gaudreau K, et al. A convenient analytic method for gel quantification using ImageJ paired with Python or R. 2024. PubMed ID: 39570862. Describes semi-quantitative analysis of nucleic acid gels using ImageJ, providing context for comparing microfluidic electrophoresis with traditional gel-based methods.

2. Han S, Liu S, Chen C. A protocol for high-quality single-cell RNA sequencing with cell surface protein quantification. 2026. PubMed ID: 41488013. Demonstrates the importance of RNA quality assessment using microfluidic electrophoresis in single-cell sequencing workflows.

3. CDC and NIH. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition. U.S. Department of Health and Human Services, 2020. Available at: https://www.cdc.gov/labs/bmbl/index.html. Authoritative guidance for biosafety practices in molecular biology laboratories.

4. National Institutes of Health. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. Available at: https://osp.od.nih.gov/policies/biosafety-and-biosecurity-policy/nih-guidelines-for-research-involving-recombinant-or-synthetic-nucleic-acid-molecules/. Regulatory framework for work with recombinant nucleic acids.

5. National Center for Biotechnology Information. NCBI Bookshelf: Molecular Biology and Laboratory Methods. Available at: https://www.ncbi.nlm.nih.gov/books/. Searchable collection of molecular biology methods and protocols.

Related Articles

• DNA Quantification Using Picogreen Assay: Protocol and Sensitivity
• DNA Quantification Using a Spectrophotometer: Nanodrop and UV-Vis Methods
• Nucleic Acid Handling: Avoiding Common Contamination Sources
• Qubit Fluorometric DNA Quantification: Protocol for High Sensitivity and Broad Range Assays
• DNA Ligation: Principles, Protocol, and Optimization
• Ethanol Precipitation of DNA: Protocol and Troubleshooting